BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 33262254)

  • 41. Natural killer cells and pigment epithelial-derived factor control the infiltrative and nodular growth of hepatic metastases in an Orthotopic murine model of ocular melanoma.
    Jones NM; Yang H; Zhang Q; Morales-Tirado VM; Grossniklaus HE
    BMC Cancer; 2019 May; 19(1):484. PubMed ID: 31117965
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metastatic ocular melanoma to the liver exhibits infiltrative and nodular growth patterns.
    Grossniklaus HE; Zhang Q; You S; McCarthy C; Heegaard S; Coupland SE
    Hum Pathol; 2016 Nov; 57():165-175. PubMed ID: 27476775
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events.
    Koch EAT; Petzold A; Dippel E; Erdmann M; Gesierich A; Gutzmer R; Hassel JC; Haferkamp S; Kähler KC; Kreuzberg N; Leiter U; Loquai C; Meier F; Meissner M; Mohr P; Pföhler C; Rahimi F; Schell B; Terheyden P; Thoms KM; Ugurel S; Ulrich J; Utikal J; Weichenthal M; Ziller F; Berking C; Heppt MV
    Front Immunol; 2024; 15():1395225. PubMed ID: 38915414
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies.
    Algazi AP; Tsai KK; Shoushtari AN; Munhoz RR; Eroglu Z; Piulats JM; Ott PA; Johnson DB; Hwang J; Daud AI; Sosman JA; Carvajal RD; Chmielowski B; Postow MA; Weber JS; Sullivan RJ
    Cancer; 2016 Nov; 122(21):3344-3353. PubMed ID: 27533448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review.
    Heppt MV; Steeb T; Schlager JG; Rosumeck S; Dressler C; Ruzicka T; Nast A; Berking C
    Cancer Treat Rev; 2017 Nov; 60():44-52. PubMed ID: 28881222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Uveal melanoma hepatic metastases mutation spectrum analysis using targeted next-generation sequencing of 400 cancer genes.
    Luscan A; Just PA; Briand A; Burin des Roziers C; Goussard P; Nitschké P; Vidaud M; Avril MF; Terris B; Pasmant E
    Br J Ophthalmol; 2015 Apr; 99(4):437-9. PubMed ID: 25361747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis.
    Koch EAT; Petzold A; Wessely A; Dippel E; Gesierich A; Gutzmer R; Hassel JC; Haferkamp S; Hohberger B; Kähler KC; Knorr H; Kreuzberg N; Leiter U; Loquai C; Meier F; Meissner M; Mohr P; Pföhler C; Rahimi F; Schadendorf D; Schell B; Schlaak M; Terheyden P; Thoms KM; Schuler-Thurner B; Ugurel S; Ulrich J; Utikal J; Weichenthal M; Ziller F; Berking C; Heppt MV; On Behalf Of The German Dermatologic Cooperative Oncology Group DeCOG Committee Ocular Melanoma
    Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34283061
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
    Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
    JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular characteristics of liver metastases from uveal melanoma.
    Meir T; Dror R; Yu X; Qian J; Simon I; Pe'er J; Chowers I
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4890-6. PubMed ID: 17962435
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integrated differential DNA methylation and gene expression of formalin-fixed paraffin-embedded uveal melanoma specimens identifies genes associated with early metastasis and poor prognosis.
    Ness C; Katta K; Garred Ø; Kumar T; Olstad OK; Petrovski G; Moe MC; Noer A
    Exp Eye Res; 2021 Feb; 203():108426. PubMed ID: 33387485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective internal radiation therapy for hepatic metastases of uveal melanoma: a systematic review.
    Alexander H; Wen D; Chu M; Han C; Hadden P; Thomas R; Bartlett A
    Br J Radiol; 2022 Jan; 95(1129):20210200. PubMed ID: 34757824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunomagnetic isolation and in vitro expansion of human uveal melanoma cell lines.
    Cools-Lartigue JJ; McCauley CS; Marshall JC; Di Cesare S; Gregoire F; Antecka E; Logan P; Burnier MN
    Mol Vis; 2008 Jan; 14():50-5. PubMed ID: 18246031
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Presence and prevalence of UV related genetic mutations in uveal melanoma: similarities with cutaneous melanoma.
    Goh AY; Ramlogan-Steel CA; Jenkins KS; Steel JC; Layton CJ
    Neoplasma; 2020 Sep; 67(5):958-971. PubMed ID: 32305056
    [TBL] [Abstract][Full Text] [Related]  

  • 54. c-MET expression in primary and liver metastases in uveal melanoma.
    Gardner FP; Serie DJ; Salomao DR; Wu KJ; Markovic SN; Pulido JS; Joseph RW
    Melanoma Res; 2014 Dec; 24(6):617-20. PubMed ID: 25211165
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes.
    van Essen TH; van Pelt SI; Bronkhorst IH; Versluis M; Némati F; Laurent C; Luyten GP; van Hall T; van den Elsen PJ; van der Velden PA; Decaudin D; Jager MJ
    PLoS One; 2016; 11(10):e0164292. PubMed ID: 27764126
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
    Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
    Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. c-Met, epidermal growth factor receptor, and insulin-like growth factor-1 receptor are important for growth in uveal melanoma and independently contribute to migration and metastatic potential.
    Wu X; Zhou J; Rogers AM; Jänne PA; Benedettini E; Loda M; Hodi FS
    Melanoma Res; 2012 Apr; 22(2):123-32. PubMed ID: 22343486
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting primary and metastatic uveal melanoma with a G protein inhibitor.
    Onken MD; Makepeace CM; Kaltenbronn KM; Choi J; Hernandez-Aya L; Weilbaecher KN; Piggott KD; Rao PK; Yuede CM; Dixon AJ; Osei-Owusu P; Cooper JA; Blumer KJ
    J Biol Chem; 2021; 296():100403. PubMed ID: 33577798
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiologic and Histopathologic Correlation of Different Growth Patterns of Metastatic Uveal Melanoma to the Liver.
    Liao A; Mittal P; Lawson DH; Yang JJ; Szalai E; Grossniklaus HE
    Ophthalmology; 2018 Apr; 125(4):597-605. PubMed ID: 29122287
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Electrochemotherapy with bleomycin and cisplatin enhances cytotoxicity in primary and metastatic uveal melanoma cell lines in vitro.
    Fiorentzis M; Kalirai H; Katopodis P; Seitz B; Viestenz A; Coupland SE
    Neoplasma; 2018; 65(2):210-215. PubMed ID: 29534581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.